Welcome to the October 2010 edition of the ISPOR eBulletin. The ISPOR eBulletin provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to see: www.ispor.org.
2011-2012 ISPOR Board of Directors–Call for Nominations
ISPOR is a member-driven organization. Your participation is essential. The activities of the organization are a response to member needs. As a member-driven organization, its governance is determined by the membership. As an ISPOR member, you are encouraged to submit a nomination to serve on the 2010-2011 ISPOR BOARD OF DIRECTORS. Self-nominations are permitted. Please email your recommendation, along with a curriculum vita, to: firstname.lastname@example.org. The deadline for submitting nominations is Tuesday, January 4, 2011.
For the 2010-2011 ISPOR Board of Directors members (including terms of office), please see:
2010-2011 ISPOR Board of Directors »
ISPOR 13th Annual European Congress, Prague, Czech Republic – OVER 1300 PRESENTATIONS
Plenary Sessions for this Congress:
Sunday, 7 November 2010 - Plenary Session I »
Monday, 8 November 2010 - Plenary Session II »
Tuesday, 9 November 2010 - Plenary Session III »
ISPOR 13th Annual European Congress »
ISPOR 4th Asia-Pacific Conference, Phuket, Thailand
Value in Health Early View Articles
The ISPOR 4th Asia-Pacific Conference was held 5-7 September 2010 at the Hilton Phuket, Phuket, Thailand.
ISPOR 4th Asia-Pacific Conference Photos »
ISPOR 4th Asia-Pacific Research Presentation
Award Recipients »
Sixteen Early View articles are available on-line, including nine new articles added in the last month.
Value in Health Early View articles »
Value in Health Volume 13, Issue 6 On-Line
Value in Health Volume 13, Issue 6 is now available on-line.
Value in Health »
Therapeutic and Diagnostic Devices Outcomes Research
Therapeutic and Diagnostic Devices Outcomes Research »
ISPOR Argentina Regional Chapter Seminars
The book, Therapeutic and Diagnostic Devices Outcomes Research, is an outcomes research primer for those in the therapeutic and diagnostics devices research and development field. Its purpose is two-fold: 1) to inform health outcomes researchers on the unique characteristics of therapeutic and diagnostic devices, and 2) to inform medical and diagnostic devices developers and researchers on basic principles of outcomes research encompassing clinical outcomes, economic outcomes and humanistic; i.e. patient reported outcomes research.
The ISPOR Argentina Regional Chapter is host to two seminars on topics of interest to academia and industry alike. The first seminar, “Assessment of Preferences in the Treatment of Rheumatoid Arthritis with Biological Agents,” was held on 23 September 2010 in Buenos Aires, Argentina. The second, to be held on 25 November 2010, is titled, “Shared Risk Reimbursement Plans,” also in Buenos Aires. For detailed program information, please see:
ISPOR Argentina Regional Chapter »
ISPOR Venezuela Regional Chapter Special ISPOR-Venezuela Bulletin
ISPOR Good Outcomes Research Practices Task Force Reports
The ISPOR Venezuela Regional Chapter proudly announces the launch of the First Special Issue of the ISPOR-Venezuela Bulletin. This issue opens a new window which will enable access to various national and international players whose professional experience has the potential to contribute to the development of pharmacoeconomics and health outcomes research in Venezuela. To view the First Special Issue, please see: ISPOR Venezuela Regional Chapter »
Please submit your comments to the following ISPOR Good Research Task Force Reports by Friday, October 8, 2010.
Indirect Treatment Comparison Task Force Report
*Interpreting Indirect Treatment Comparison for Decision-making – Part 1: FOR COMMENT
*Indirect Treatment Comparison GRP for Researcher – Part 2: FOR COMMENT
Send your comments for these reports to: email@example.com
Conjoint Analysis in Health
*Conjoint Analysis Use in Health Studies – A Checklist: FOR COMMENT
Send your comment to this report to: Conjoint_analysis@ispor.org
For more information, please see:
ISPOR Indirect Treatment Comparisons Good Research Practices Task Force »
ISPOR Good Outcomes Research Practices for Conjoint Analysis Task Force »
ISPOR Health Technology Assessment (HTA) SIG Workshop
The ISPOR Health Technology Assessment of Medical Devices & Diagnostics Working Group of the ISPOR HTA SIG will be presenting a Workshop, “Considerations For Technology Assessments Of Diagnostic Products” at the ISPOR 13th Annual European Congress, Prague, Czech Republic on Tuesday 9 November 2010.
ISPOR HTA SIG Workshop: Considerations For Technology Assessments Of Diagnostic Product »
ISPOR Health Technology Assessment (HTA) SIG: ISPOR Global Health Care Systems Road Map
Later in October 2010, information on medical devices reimbursement and coverage systems for 5 countries (Canada, Mexico, Italy, Mainland China, Germany) and Pharmaceutical reimbursement systems information on Singapore will be posted.
ISPOR Global Health Care Systems Road Map »
ISPOR HTA Group Seeking Volunteers
ISPOR Global Health Care Systems Road Map »
TIP OF THE MONTH- Research Podium and Poster Presentation Awards
The HTA SIG group is continuously seeking volunteers to contribute information on new countries for the ISPOR Global Health Care Systems Road Map. The Road Map provides an overview of country-specific health care systems focusing on reimbursement systems, describes key decision-making players and decision-making processes for coverage and pricing. For more information, please see:
PDF presentations and photos of presenters of ISPOR's Research Podium and Poster Presentation recipients from past ISPOR Meetings, Congresses and Conferences can be found by going to the Awards tab on the purple toolbar on the ISPOR homepage, select Scientific Achievement Awards, and selecting any of the highlighted past meetings, congresses, or conferences from the Research Podium or Poster Research awards.
European School of Health Economics
February 21-25, March 21-25, and April 11-15, 2011
Nice (Cannes), France
The next international training program of the European School of Health Economics will take place in Nice (Cannes), France, on February 21-25, March 21-25, and April 11-15, 2011.
The course “HEALTH ECONOMICS OF PHARMACEUTICALS AND OTHER MEDICAL INTERVENTIONS (HEPaMI 2011)” covers:
- the international health-care environment
- theory and methods of economic evaluation of health care programs
- reimbursement, health technology assessment, market access
Gisela Kobelt, European Health Economics (France) and Lund University (Sweden)
|| University of Glasgow, UK
||Brunel University, London, UK
|| University of York, UK
||University of Budapest, Hungary
|| Ministry of Health, Norway
||Stockholm School of Economics, Sweden
|Gérard de Pouvourville
||ESSEC, Paris, France
||EMEA, London, UK
||John Hopkins University, Baltimore, USA
|Matthias vd Schulenburg
||University of Hanover, Germany
||Office of Health Economics, London, UK
Specialists from the pharmaceutical/diagnostic/medical device industries and consulting companies.
More information can be downloaded from www.he-europe.com. Enrollment is open on internet, or by mail/fax. For more details, please contact Gisela Kobelt, tel +33-608-075-390,
Available Online: Cardiometabolic Risk Simulation Dataset
Archimedes Inc., the healthcare modeling company founded by Dr. David Eddy, is about to make available a simulation dataset of 100,000 people at risk for cardiovascular and metabolic diseases such as stroke, MI and diabetes. Using the newly developed Archimedes Outcomes Analyzer, anyone can understand, share, and compare the effects of 22 interventions currently recommended in national guidelines and performance measures. Researcher can explore health and biological outcomes, utilization, medical costs, and cost-effectiveness.
For more information visit: http://www.outcomesanalyzer.com
Economic Evaluation in Clinical Trials
- A Two-day Practical Course
21-22 October 2010
Princeton, NJ, USA
|For the first time in North America, Dr. Henry Glick from the University of Pennsylvania presents a two-day practical course on ‘Economic Evaluation in Clinical Trials’. Aimed at health economists, medical statisticians and clinical trialists working to support drug development programmes, this course will explore design and analysis issues related to economic appraisal of pharmaceuticals and is based on the best-selling OUP Handbook of the same title.
This two-day course will run on 21st & 22nd October 2010 at the Nassau Inn, Princeton, NJ, USA.
Dr. Henry Glick will be joined on the faculty by Dr. Jalpa Doshi, University of Pennsylvania, and Dr. Andrew Briggs, University of Glasgow, UK.
The course is practical and didactic sessions will be followed by practical sessions using the statistical package STATA. A copy of STATA will be provided, but participants should bring their own PC laptop on which to perform the practical sessions.
Participants will also receive a copy of Dr. Glick’s book.
The course carries a fee of US$1,450 which is fully inclusive of tuition, lunch, course dinner and course materials, including a copy of Dr. Glick’s ‘Economic Evaluation in Clinical Trials’, but which excludes accommodation.
Further information can be found here.
Ten spaces left at discounted rate of $950.
Please register your interest with Anne Marie McLean
(firstname.lastname@example.org) as soon as possible as the intensive nature of the practical sessions means that the places for this course are limited.
ISPOR celebrates 15 years of growth and accomplishments.
6-9 November 2010
ISPOR 13th Annual European Congress
January 13, 2011
ISPOR 16th Annual International Meeting Abstracts Deadline